Fig. 6From: Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancerVerification of the core gene of the risk signature in an independent cohort. a Representative images of low and high expression of DPY30. b Kaplan–Meier analysis of OS of the expression of DPY30 in the independent cohort. c Representative images of poorly-, moderately-, and well-differentiated pancreatic cancer. d DPY30 expression levels in poorly-, moderately- and well-differentiated pancreatic cancers in the independent cohortBack to article page